Inflammatory bowel disease: The problems of dysplasia and surveillance

Techniques in Coloproctology

Volumn 11, Issue 4, 2007, Pages 299-309

  Mitchell, P J ^a   Salmo, E ^b   Haboubi, N Y ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Crohn's disease; Dysplasia; Surveillance; Ulcerative colitis

Indexed keywords

CANCER RISK; COLON RESECTION; COLONOSCOPY; COLORECTAL CARCINOMA; DISEASE CLASSIFICATION; DISEASE DURATION; DYSPLASIA; ENTERITIS; HUMAN; ILEUM POUCH; REVIEW;

COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 38649096290     PISSN: 11236337     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10151-007-0386-2     Document Type: Review

References (102)

1. Crohn B, Rosenberg H (1925) The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 170:220-228
2. Rutter MD, Saunders BP, Wilkinson KH et al (2006) Thirty year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130:1030-1038
3. Eaden JA, Abrams KA, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526-535
4. Itzkowitz SH, Present DH (2005) Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11:314-321
5. Rubin DT, Kavitt RT (2006) Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin N Am 35:581-604
6. de Dombal FT, Watts JM, Watkinson G, Goligher JC (1966) Local complications of ulcerative colitis: stricture, pseudopolyposis and carcinoma of the colon and rectum. Br Med J 1:1442-1447
7. MacDermott RP (1985) Review of clinical aspects of the colon in patients with ulcerative colitis. Dig Dis Sci 30:114S-118S
8. Gyde SN, Prior P, Allan RN et al (1988) Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 29:206-217
9. BroomÈ U, Lindberg G, Lofberg R (1992) Primary sclerosing cholangitis in ulcerative colitis - a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 102:1877-1880
10. Jayaram H, Satsangi J, Chapman RW (2001) Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut 48:430-434
11. Shetty K, Rybicki L, Brzezinski, A, Carey WD, Lashner BA (1999) The risk of cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 94:1643-1649
12. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56:48-54
13. Askling J, Dickman PW, Karlen P et al (2001) Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120:1356-1362
14. Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM, Lindor NM. (1998) Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case control study. Gastroenterology 115:1079-1083
15. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 323:1228-1233
16. Rutter MD, Saunders BP, Wilkinson KH et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451-459
17. Rutter M, Saunders B, Wilkinson KH et al (2004) Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 53:1813-1816
18. Warren S, Sommers SC (1948) Cicatrizing enteritis as a pathological entity. Am J Pathol 24:475-501
19. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH (1981) A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 48:2742-2745
20. Gyde SN, Prior P, MacCartney JC, Thompson H, Waterhouse JA, Allan RN (1980) Malignancy in Crohn's disease. Gut 21:1024-1029
21. Ekbom A, Helmick C, Zack M, Adami HO (1990) Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336:357-359
22. Gillen CD, Andrews HA, Prior P, Allan RN (1994) Crohn's disease and colorectal cancer. Gut 35:651-656
23. Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23:1097-1104
24. Friedman S (2006) Cancer in Crohn's disease. Gastroenterol Clin N Am 35:621-639
25. Ribeiro MB, Greenstein AJ, Sachar DB et al (1996) Colorectal adenocarcinoma in Crohn's disease. Ann Surg 223:186-193
26. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF (1973) Crohn's disease and cancer. N Engl J Med 289:1099-1102
27. Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH, Greenstein AJ (1991) Malignant colorectal strictures in Crohn's disease. Am J Gastroenterol 86:882-885
28. Stahl TJ, Schoetz DJ, Roberts PL et al (1992) Crohn's disease and carcinoma: increasing justification for surveillance? Dis Colon Rectum 35:850-856
29. Greenstein AJ, Sachar DB, Pucillo A et al (1978) Cancer in Crohn's disease after diversionary surgery: a report of seven carcinomas occurring in excluded bowel. Am J Surg 135:86-90
30. Itzkowitz SH, Yio X (2004) Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Gastrointest Liver Physiol 287:G7-G17
31. Burmer GC, Rabinovitch PS, Haggitt RC et al (1992) Neoplastic progression in ulcerative colitis: histology, DNA content and loss of p53 allele. Gastroenterology 103:1602-1610
32. Hoque AT, Hahn SA, Schutte M, Kern SE (1997) DPC4 gene mutation in colitis associated neoplasia. Gut 40:120-122
33. Umetani N, Sasaki S, Watanabe T et al (1999) Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability. Jpn J Cancer Res 90:1081-1087
34. Schulmann K, Mori Y, Croog V et al (2005) Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology 129:74-85
35. Herszenyi L, Miheller P, Tulassay Z (2007) Carcinogenesis in inflammatory bowel disease. Dig Dis 25:267-269
36. Riddell RH, Goldman H, Ransohoff DF et al (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14:931-968
37. Warren S, Sommers SC (1949) Pathogenesis of ulcerative colitis. Am J Pathol 25:657-679
38. Collins RH, Feldman M, Fordman JS (1987) Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: a critical review. N Engl J Med 316:1654-1658
39. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH (1994) Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107:934-944
40. Melville DM, Jass JR, Morson BC et al (1989) Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 20:1008-1014
41. Dixon NF, Brown LJR, Gilmour HM et al (1988) Observer variation in the assessment of dysplasia of ulcerative colitis. Histopathology 13:385-398
42. Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel disease. Gastroenterology 126:1634-1648
43. Stange EF, Travis SPL, Vermeire S et al for the European Crohn's and Colitis Organisation (ECCO) (2006) European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 55:i1-i15
44. Rubin CE, Haggitt RC, Burmer GC et al (1992) DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103:1611-1620
45. Kornbluth A, Sachar DB (2004) Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 99:1371-1385
46. Eaden JA, Mayberry JF (2002) Guidelines for the screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51:10-12
47. Bernstein CN, Weinstein WM, Levine DS, Shanahan F (1995) Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 90:2106-2114
48. Eaden JA, Ward BA, Mayberry JF (2000) How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 51:123-128
49. Linberg B, Perrson B, Veress B, Ingel-Sundberg H, Granqvist S (1996) Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol 31:1195-1204
50. Ullman TA, Loftus EV Jr, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ (2002) The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 97:922-927
51. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz SH (2003) Progression of flat low grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125:1311-1319
52. Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343:71-74
53. Taylor BA, Pemberton JH, Carpenter HA et al (1992) Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 35:950-956
54. Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, Axon AT (2003) Ten-year follow-up of ulcerative colitis patients with and without low grade dysplasia. Gut 52:1127-1132
55. Befrits R, Ljung T, Jaramillo E, Rubio C (2002) Low grade dysplasia in extensive long standing inflammatory bowel disease: a follow up study. Dis Colon Rectum 45:615-620
56. Rodriguez SA, Collins JM, Knigge KL, Eisen GM (2007) Surveillance and management of dysplasia in ulcerative colitis. Gastrointest Endosc 65:432-439
57. Blackstone MO, Riddell RH, Rogers BH. Levin B (1981) Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80:366-374
58. Ludeman L, Shephard NA (2006) Problem areas in the pathology of chronic inflammatory bowel disease. Curr Diagn Pathol 12:248-260
59. Goldblum JR (2003) The histologic diagnosis of dysplasia, dysplasia associated lesion or mass, and adenoma. A pathologists' perspective. J Clin Gastroenterol 36:S63-S69
60. Torres C, Antonioli D, Odze RD (1998) Polypoid dysplasia and adenomas in inflammatory bowel disease; a clinical, pathologic and follow-up study of 89 polyps from 50 patients. Am J Surg Pathol 22:275-284
61. Rutter CE, Saunders DP, Wilkinson KH, Kamm MA, Williams CB, Forbes A (2004) Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 103:1611-1620
62. Odze RD, Farraye FA, Hecht JL, Hornick JL (2004) Longterm follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2:534-541
63. Rubin PH, Friedman S, Harpaz N et al (1999) Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 117:1295-1300
64. Farraye FA, Waye JD, Moscandrew M, Heeren TC, Odze RD (2007) Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an internet based study. Gastrointest Endosc 66:519-529
65. Hurlstone DP, Sanders DS, Atkinson R et al (2007) Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic paradigm? Gut 56:838-846
66. Morson BC, Pang LSC (1967) Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8:423-434
67. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB (1983) Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet 2:149-152
68. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A (1990) Colonoscopic surveillance in long standing total ulcerative colitis - A 15-year follow up study. Gastroenterology 99:1021-1031
69. Rozen P, Baratz M, Ferer F, Gilat T (1995) Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 108:1361-1370
70. Lashner BA, Kane SV, Hanauer SB (1990) Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 85:1083-1087
71. Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC (1993) Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105:418-424
72. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A (1998) Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42:711-714
73. Collins PD, Mpofu C, Watson AJ, Rhodes JM (2006) Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 19:CD000279
74. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH (2001) Screening and surveillance colonoscopy on chronic Crohn's colitis. Gastroenterology 120:820-826
75. Choi PM, Zelig MP (1994) Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35:950-954
76. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RA (1994) Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35:1590-1592
77. Bernstein CN, Blanchard JF, Kliewer E, Wadja A (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854-862
78. Svreck M, Cosnes J, Beaugerie L et al (2007) Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology 50:574-583
79. Sacchar DB (1994) Cancer in Crohn's disease: dispelling the myths. Gut 35:1507-1508
80. Parks AG, Nicholls RJ (1978) Proctocolectomy without ileostomy for ulcerative colitis. Br Med J 2:85-88
81. Lovegrove RE, Constantinides VA, Heriot AG et al (2006) A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy. Ann Surg 244:18-26
82. Fazio VW, Ziv Y, Church JM et al (1995) Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 222:120-127
83. Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH (1998) J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 85:800-803
84. Lofberg R, Liljeqvist L, Lindquist K, Veress B, Reinholt FP, Tribukait B (1991) Dysplasia and DNA aneuploidy in a pelvic pouch. Report of a case. Dis Colon Rectum 34:280-283
85. Herline AJ, Meisinger LL, Rusin LC et al (2003) Is routine pouch surveillance for dysplasia indicated for ileoanal pouches? Dis Colon Rectum 46:156-159
86. Borjesson L, Willen R, Haboubi NY, Duff SE, Hulten L (2004) The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study. Colorectal Dis 6:494-498
87. Thompson-Fawcett MW, Marcus V, Redston M, Cohen Z, McLeod RS (2001) Risk of dysplasia in long term ileal pouches and pouches with chronic pouchitis. Gastroenterology 12:275-281
88. Veress B, Reinholt FP, Lindquist K, Lofberg R, Liljeqvist L (1995) Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a sub-group of patients. Gastroenterology 109:1090-1097
89. Gullberg K, Stahlberg D, Liljeqvist L et al (1997) Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology 112: 1487-1492
90. Remzi FH, Fazio VW, Delaney CP et al (2003) Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum 46:6-13
91. Tsunoda A, Talbot IC, Nicholls RJ (1990) Incidence of dysplasia in the anorectal mucosa in patients having restorative proctocolectomy. Br J Surg 77: 506-508
92. Coull DB, Lee FD, Anderson JH, McKee RF, Finlay IG, Dunlop MG (2006) Long-term cancer risk of the anorectal cuff following restorative proctocolectomy assessed by p53 expression and cuff dysplasia. Colorectal Disease 9:321-327
93. Das P, Johnson MW, Tekkis PP, Nicholls RJ (2007) Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 9:15-27
94. Carter MJ, Lobo AJ, Travis SP (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53:V1-V16
95. Chambers WM, Warren BF, Jewell DP, Mortensen NJ (2005) Cancer surveillance in ulcerative colitis. Br J Surg 92:928-936
96. Rosenstock E, Farmer RG, Petras R, Sivak MV Jr, Rankin GB, Sullivan BH. (1985) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 89:1342-1346
97. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB (1990) Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 31: 800-806
98. Provenzale D, Wong JB, Onken JE, Lipscomb J (1998) Performing a cost effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol 93:872-880
99. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC (2004) Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 53:256-260
100. Kiesslich R, Fritsch J, Holtmann M et al (2003) Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124: 880-888
101. Chen R, Rabinovitch PS, Crispin DA et al (2003) DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol 162:665-672
102. Selaru FM, Xu Y, Yin J et al (2002) Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology 122:606-613